JB Chemicals & Pharmaceuticals Limited filed its Business Responsibility and Sustainability Report for FY 2025-26. The report details company ESG performance, sustainability targets, and governance frameworks.
JB Chemicals & Pharmaceuticals filed its FY26 Business Responsibility and Sustainability Report. The filing highlights its ₹3889.89 Crore turnover and ESG progress for investor review.
JB Chemicals & Pharmaceuticals released its FY26 Integrated Annual Report, recording ₹4,148 Crore revenue. The company maintains strong growth momentum in domestic cardiology and international markets.